I am a board-certified hematologist and medical oncologist and I work as part of a multidisciplinary team caring for people with hematologic malignancies. My specific expertise is in using cellular therapy and allogeneic hematopoietic cell transplant to treat hematologic malignancies. I am also engaged in laboratory and clinical research investigating cellular therapy with CD19-targeted chimeric antigen receptor (CAR) T cells following transplant in order to improve transplant outcomes.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicare and New York State Medicaid also provide benefits for care at MSK.Learn more